Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
During the first month, patients commonly experience mild to moderate nausea, which typically improves with continued use
Rheumatology 60 , 28162825 (2020)
Why It Works: Modulates nitric oxide bioavailability at the eNOS level, helping stabilize the balance between vasodilation and vasoconstriction in injured tissue Upregulates VEGFR2 expression and drives VEGF-mediated angiogenesis, supporting new blood vessel formation at injury sites Protects cell-matrix adhesion through FAK-paxillin signaling and appears to dampen local inflammatory cascades via NF-B modulation Best For: Tendon, ligament, and soft-tissue injury recovery, along with gut-lining and gastrointestinal repair research Typical Protocol: Preclinical/research protocols commonly reference 200-500 mcg per day via subcutaneous injection, split into one or two daily doses (with 250 mcg once or twice daily being a frequently cited starting range)
Anticancer Drugs
